Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix (Q56994969)

From Wikidata

Jump to navigation Jump to search

No description defined

Language	Label	Description	Also known as
English	Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix	No description defined

Statements

scholarly article

0 references

Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix (English)

0 references

1 reference

based on heuristic

inferred from title

adenocarcinoma in situ

1 reference

based on heuristic

inferred from title

human papilloma virus

1 reference

object named as

human papillomavirus

29 September 2024

based on heuristic

inferred from title

Stina Syrjänen

8

object named as

Stina Syrjanen

0 references

9

object named as

Kari Syrjanen

0 references

author name string

Silvano Costa

1

0 references

Giovanni Negri

2

0 references

Mario Sideri

3

0 references

Donatella Santini

4

0 references

Giuseppe Martinelli

5

0 references

Simona Venturoli

6

0 references

Carla Pelusi

7

0 references

Giuseppe Pelusi

10

0 references

language of work or name

0 references

publication date

July 2007

0 references

Gynecologic Oncology

0 references

106

0 references

1

0 references

170-6

0 references

The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Epidemiology of adenocarcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Can glandular lesions be diagnosed in pap smear cytology?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Adenocarcinoma in situ of the uterine cervix: screening and diagnostic errors in Papanicolaou smears

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

The role of human papillomavirus in cervical adenocarcinoma carcinogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Invasive cervical adenocarcinoma immediately following a cone biopsy for adenocarcinoma in situ with negative margins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Adenocarcinoma in situ and early invasive adenocarcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Cervical adenocarcinoma in situ: a systematic review of therapeutic options and predictors of persistent or recurrent disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Is electrosurgical loop excision with negative margins sufficient treatment for cervical ACIS?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Symposium part I: adenocarcinoma in situ, glandular dysplasia, and early invasive adenocarcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Disease persistence in patients with cervical intraepithelial neoplasia undergoing electrosurgical conization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Adenocarcinoma in situ of the uterine cervix: management and outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Can cervical adenocarcinoma in situ be safely managed by conization alone?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Is laser conization adequate for therapeutic excision of adenocarcinoma in situ of the uterine cervix?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Further study of the management of cervical adenocarcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Adenocarcinoma in situ of the cervix: management and outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Adenocarcinoma in situ of the cervix: a prospective study of conization as definitive treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Adenocarcinoma in situ of the cervix: significance of cone biopsy margins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

The anatomic distribution of cervical adenocarcinoma in situ: implications for treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Adequacy of Conization Margins in Adenocarcinomain Situof the Cervix as a Predictor of Residual Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Adenocarcinoma in situ of the uterine cervix: a clinico-pathologic study of 36 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Conservative management of adenocarcinoma in situ of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

High-risk human papillomavirus DNA testing: a marker for atypical glandular cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Is improved detection of adenocarcinoma in situ by screening a key to reducing the incidence of cervical adenocarcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.016

7 January 2021

Identifiers

10.1016/J.YGYNO.2007.03.016

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56994969&oldid=2254264112"